Adequate muscle reserves are a critical component of cancer survival. This webinar will synthesize current literature across cancers to demonstrate the protective effects of muscle in cancer survival. We will also discuss the use of clinically available CT scans to measure muscle in cancer patients and potential mechanisms of why muscle is important in cancer survival.
The session will present data from studies in non-metastatic breast and colorectal cancer which demonstrate how muscle affects other outcomes chemotoxicity, surgical outcomes and co-morbidities. Lastly, we will review ways to include evaluation of sarcopenia into clinical work-ups for cancer patients.
- Describe the correlation between sarcopenia and cancer outcomes
- Explain the import of muscle/sarcopenia on cancer outcomes among cancer survivors
- Outline diets which aid in preserving muscle mass in cancer patients
Dr. Carla Prado, PhD, RDN is an assistant professor at UAlberta, and a Campus Alberta Innovates Chair in Nutrition, Food and Health. She is also the director of the Human Nutrition Research Unit. Prado is an internationally recognized expert in assessing nutritional status of different populations through the precise measurement of body composition and energy metabolism. The focus of her current research program is to develop specific nutrition strategies for the prevention and treatment of muscle loss.
Bette Caan, DrPH, is a senior research scientist and a nutritional epidemiologist at the Kaiser Permanente Northern California Division of Research. She has been at the Division of Research since 1983. Dr. Caan has authored or co-authored 290 publications while a researcher at DOR. Her research publications cover a wide range of topics, primarily in nutrition and body size, cancer epidemiology and women's health.